Target intelligence / Profile preview

Proapoptotic nucleolar protein 1 (PANO1)

Target
PANO1
Molecular classification
Other (Nucleolar protein)
01

Overview

Proapoptotic nucleolar protein 1 (PANO1) is a nucleolar protein that induces apoptosis and participates in tumor suppression pathways. It achieves this mainly by modulating and stabilizing the tumor suppressor protein CDKN2A/p14ARF, thus protecting it from degradation. By doing so, PANO1 may contribute to enhanced cell cycle arrest and apoptosis in response to cellular stress, and it has been postulated as a potential tumor suppressor[5]. PANO1 localizes primarily to the nucleolus and is involved in several regulatory processes, notably the negative regulation of proteasomal ubiquitin-dependent protein catabolic process and positive regulation of apoptotic pathways[5]. It is also known by the alias "pre-mRNA-splicing factor cwc22-like" in some databases, likely based on gene orthology, but its primary established function is apoptosis induction and tumor suppression rather than splicing[4][5][6]. There are no current drugs targeting PANO1 directly, and it is not yet a clinically established biomarker. The major research focus is its role in cell death and cancer biology.

Other names
PANO1PANOpre-mRNA-splicing factor cwc22-likeAP006621.6
02

Biological functions

ApoptosisRegulation of protein stabilityRegulation of the tumor suppressor CDKN2A/p14ARFNegative regulation of proteasomal ubiquitin-dependent protein catabolic process
03

Disease associations

Cancer (tumor suppressor context)Other (disease annotation includes Narcissistic Personality Disorder, but primary focus is on cancer/tumor suppressor pathway)

Beyond the preview

Go deeper on Proapoptotic nucleolar protein 1 (PANO1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Proapoptotic nucleolar protein 1 (PANO1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call